Windtree Therapeutics receives Nasdaq delisting notice; stock to trade OTC Aug 21

WINDTREE THERAPEUTICS INC /DE/

Nasdaq notified Windtree of delisting due to noncompliance with Listing Rule 5550(a)(2) (minimum bid price).
Trading on Nasdaq will be suspended at open on August 21, 2025.
Common stock expected to trade on OTC markets under symbol WINT, pending approval for OTCID tier.
Company will continue filing periodic reports with SEC; business operations unaffected.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.